Skip to main content

Concepció Jacobs Cachá

Institutions of which they are part

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Concepció Jacobs Cachá

Institutions of which they are part

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Projects

Modelo predictivo del riesgo de infección y rechazo después del trasplante renal basado en la combinadición de parámetros clínicos y biomarcadores.

IP: Francesc Moreso Mateos
Collaborators: Joana Sellarés Roig, Concepció Jacobs Cachá, Manel Perelló Carrascosa, Romina Dieli Crimi, Nestor Gabriel Toapanta Gaibor, Romina Dieli Crimi
Funding agency: Instituto de Salud Carlos III
Funding: 87120
Reference: PI18/01832
Duration: 01/01/2019 - 31/12/2022

Relación entre los niveles de tacrolimus y/o dosis de micofenolato y la modulación de los genes de rechazo en biopsias de seguimiento del aloinjerto renal

IP: Daniel Serón Micas
Collaborators: Joana Sellarés Roig, Concepció Jacobs Cachá, Manel Perelló Carrascosa
Funding agency: Instituto de Salud Carlos III
Funding: 81070
Reference: PI18/01704
Duration: 01/01/2019 - 31/12/2021

Apolipoproteína AIb como biomarcador y diana terapéutica de la glomeruloesclerosis segmentaria y focal idiopática (GESF)

IP: Joan López Hellin
Collaborators: José Antonio Arranz Amo, Joana Sellarés Roig, Maria Teresa Salcedo Allende, Concepció Jacobs Cachá
Funding agency: Instituto de Salud Carlos III
Funding: 88935
Reference: PI14/00275
Duration: 01/01/2015 - 30/06/2018

Promoting regeneration versus tubulointerstitial fibrosis in progressive renal disease: Novel molecular pathways

IP: Promoting regeneration versus tubulointerstitial fibrosis in progressive renal disease: Novel molecular pathways
Collaborators: Joan López Hellin, Maria Teresa Salcedo Allende, Concepció Jacobs Cachá
Funding agency: Sociedad Española de Nefrología (S.E.N.)
Funding: 18000
Reference: SENEFRO-2012-01
Duration: 06/10/2012 - 05/10/2014

Related news

On April 18 and 19, the Vall d’Hebron Research Institute (VHIR) will once again join the Science Festival 2026 with a diverse and participatory program focused on health, innovation, and citizen engagement in research.

The study results show that the local presence of IL-1β promotes the development of myeloid cells with an immunosuppressive function.

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

Related professionals

Mireia Caralt Barba

Mireia Caralt Barba

Senior researcher
General Surgery
Read more
Tomàs Pumarola Suñé

Tomàs Pumarola Suñé

Main researcher
Microbiology
Read more
Luis Enrique Lara Moctezuma

Luis Enrique Lara Moctezuma

Kidney Physiopathology
Read more
Anna Salo Rovira

Anna Salo Rovira

Research technician
Childhood Cancer and Blood Disorders
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.